On 28 May 2024, Asahi Kasei Corporation announced a recommended public cash offer to the shareholders and ADS holders of Calliditas Therapeutics AB (publ). The offer values all shares and ADSs in Calliditas at SEK 11,164 million. The shares in Calliditas are listed on Nasdaq Stockholm and the ADSs in Calliditas are listed on Nasdaq Global Select Market.

Gernandt & Danielsson advises Asahi Kasei with a team led by partner Fredrik Palm, senior associates Daniel Sveen and Simona Stenborg as well as associates Siri Telmen and Jacob Linder, primarily assisted by partners Niclas Rockborn, Andreas Holmqvist and Foad Hoseinian, counsel Erika Olofsson, senior associates Arijan Kan and Astrid Svensson as well as associates Sofie Hallén, Sofia Hagelqvist and Edvin Andersson.